Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more
Tandem Diabetes Care Inc - Asset Resilience Ratio
Tandem Diabetes Care Inc (TNDM) has an Asset Resilience Ratio of 22.93% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Tandem Diabetes Care Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Tandem Diabetes Care Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $202.03 Million | 22.93% |
| Total Liquid Assets | $202.03 Million | 22.93% |
Asset Resilience Insights
- Good Liquidity Position: Tandem Diabetes Care Inc maintains a healthy 22.93% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Tandem Diabetes Care Inc Industry Peers by Asset Resilience Ratio
Compare Tandem Diabetes Care Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Tandem Diabetes Care Inc (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Tandem Diabetes Care Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 22.93% | $202.03 Million | $881.11 Million | -15.21pp |
| 2024-12-31 | 38.14% | $369.10 Million | $967.66 Million | -4.79pp |
| 2023-12-31 | 42.94% | $409.04 Million | $952.66 Million | +0.73pp |
| 2022-12-31 | 42.21% | $444.38 Million | $1.05 Billion | -18.84pp |
| 2021-12-31 | 61.05% | $552.63 Million | $905.14 Million | +6.57pp |
| 2020-12-31 | 54.48% | $390.32 Million | $716.41 Million | +16.07pp |
| 2019-12-31 | 38.42% | $125.28 Million | $326.11 Million | -3.85pp |
| 2018-12-31 | 42.27% | $87.20 Million | $206.29 Million | +41.77pp |
| 2017-12-31 | 0.50% | $479.00K | $95.35 Million | -7.38pp |
| 2016-12-31 | 7.88% | $8.86 Million | $112.39 Million | -14.51pp |
| 2015-12-31 | 22.39% | $28.02 Million | $125.12 Million | -11.52pp |
| 2014-12-31 | 33.91% | $36.11 Million | $106.46 Million | +30.77pp |
| 2013-12-31 | 3.14% | $5.10 Million | $162.22 Million | +3.02pp |
| 2012-12-31 | 0.13% | $50.00K | $39.82 Million | -0.23pp |
| 2011-12-31 | 0.36% | $50.00K | $13.98 Million | -- |